Incyte's Other Operating Expenses changed N/A to $242.3 million in Q2 2025 from the same period last year, while for Dec 2025 it was $327.0 million, marking a year-over-year increase of 44982.93%. This contributed to the annual value of $242.3 million for FY2025, which is N/A changed from last year.
Per Incyte's latest filing, its Other Operating Expenses stood at $242.3 million for Q2 2025.
Over the past 5 years, Incyte's Other Operating Expenses peaked at $242.3 million during Q2 2025, and registered a low of $34.5 million during Q3 2022.
For the 5-year period, Incyte's Other Operating Expenses averaged around $73.9 million, with its median value being $59.5 million (2024).
Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 3363.89% in 2022, then surged by 7619.85% in 2023.
Quarter analysis of 5 years shows Incyte's Other Operating Expenses stood at $53.1 million in 2021, then surged by 55.26% to $82.4 million in 2022, then grew by 13.24% to $93.3 million in 2023, then plummeted by 36.28% to $59.5 million in 2024, then surged by 307.32% to $242.3 million in 2025.
Its Other Operating Expenses was $242.3 million in Q2 2025, compared to $84.8 million in Q1 2025 and $59.5 million in Q1 2024.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value